Soft Tissue Other
| Primary Site | Histology | Schema Discriminator 2 |
|---|---|---|
| C390, C398-C399, C420-C424, C440-C449, C760-C765, C767-C768, C770-C775, C778-C779 | 8710-8714, 8800-8934, 8963-8964, 8990-8992, 9010-9045, 9120-9138, 9141-9262, 9271-9290, 9320-9330, 9364-9373, 9540, 9542-9582 | <Any value> |
| C473, C475, C493-C495 | 8000-8803, 8810-8921, 8932-8934, 8940-8990, 8992, 9000-9016, 9030-9043, 9045-9138, 9141-9230, 9240-9580, 9582 | 9 |
| C571-C579, C740-C749, C809 | 8710-8714, 8800-8803, 8810-8814, 8816-8818, 8820-8858, 8860-8900, 8902-8905, 8921, 8932-8934, 8963-8964, 8990, 8992, 9010-9016, 9030-9043, 9045, 9121-9132, 9135-9138, 9141-9175, 9181-9221, 9230, 9240-9262, 9271-9290, 9320-9330, 9364-9365, 9370-9373, 9540, 9542-9580, 9582 | <Any value> |
| C696, C698 | 8859, 8930-8931, 8991, 9020, 9180, 9222, 9231, 9366-9368 | <Any value> |
Notes
**See table above for primary sites and histologies for this schema** **Note 1:** **Sources used in the development of this schema** * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx **Note 2:** **Summary Stage** * Summary Stage is the only applicable staging system for this site/histology/schema.Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | No |
NAACCR #390
dateOfDiagnosis |
None | ||
| Primary Site | Yes |
NAACCR #400
primarySite |
None | ||
| Histology | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | ||
| Behavior | No |
NAACCR #523
behaviorCodeIcdO3 |
None | ||
| Schema Discriminator 1 | No |
NAACCR #3926
schemaDiscriminator1 |
CCCR/Canada COC NPCR SEER |
SSDI | |
| Schema Discriminator 2 | Yes |
NAACCR #3927
schemaDiscriminator2 |
All | SSDI | |
| Type of Reporting Source | No |
NAACCR #500
typeOfReportingSource |
None | ||
| Tumor Size Clinical | No |
NAACCR #752
tumorSizeClinical |
None | ||
| Tumor Size Pathological | No |
NAACCR #754
tumorSizePathologic |
None | ||
| Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
| Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
| Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
| EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
| EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
| EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
| SS2018 | No |
NAACCR #764
summaryStage2018 |
None | ||
| Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
| Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
| Grade Post Therapy Clin (yc) | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI | |
| Grade Post Therapy Path (yp) | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI | |
| Bone Invasion | 8 | No |
NAACCR #3815
boneInvasion |
COC SEER 2018–2023 SEER (RC) 2024– |
SSDI |
| Neoadjuvant Therapy | 9 | No |
NAACCR #1632
neoadjuvantTherapy |
SEER 2021– | SSDI 2021– |
| Neoadjuvant Therapy – Clinical Response | 99 | No |
NAACCR #1633
neoadjuvTherapyClinicalResponse |
SEER 2021– | SSDI 2021– |
| Neoadjuvant Therapy – Treatment Effect | 9 | No |
NAACCR #1634
neoadjuvTherapyTreatmentEffect |
SEER 2021– | SSDI 2021– |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Schema ID | 00459 |
NAACCR #3800
schemaId |
None | |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None | |
| Derived Summary Grade 2018 | <BLANK> |
NAACCR #1975
derivedSummaryGrade2018 |
None |